A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Heart Transplant Infection
- Hepatitis C
- Kidney Transplant; Complications
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04508907
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Bashar A Aqel Mayo Clinic